During a live event, Matthew Lunning, DO, interpreted long-term outcomes of the ZUMA-7 and TRANSFORM trials.
Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback